Journal of General Internal Medicine

, Volume 8, Issue 12, pp 688–690 | Cite as

Abuse potential of various opioid medications

  • Daniel Brookoff
Brief Reports


The abuse potentials of various narcotic medications were assessed by surveying 130 hospital patients who admitted to having abused prescription narcotics within the preceding six months. 85% of the subjects surveyed reported having tried controlled-release narcotic preparations for abuse purposes and 60% reported that they were of little or no use. To obtain another index of abuse potential, the author asked the subjects to estimate the street prices of various medications. The street prices of controlled-release formulations were lower than those of other narcotic medications and those of some uncontrolled nonnarcotic medications. These results suggest that controlled-release narcotic formulations may have a lower potential for abuse than do other narcotic medications. In situations where there is concern about potential abuse or diversion of prescribed narcotics, controlled-release preparations may be an appropriate alternative to high-peaking, rapid-onset opioid formulations.

Key words

narcotics opioids drug abuse prescribing controlled-release medications 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sigler KA, Guernsey BG, Ingrim NB, Buesing AA. Effect of triplicate prescription law on prescribing of schedule II drugs. Am J Hosp Pharm. 1985;42:857–9.Google Scholar
  2. 2.
    Weintraub M, Singh S, Byrne L, Maharaj K, Guttmacher L. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations. JAMA. 1991;266:2392–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Zullich SG, Grasela TH, Fiedler-Kelly JB, Gengo FM. Impact of triplicate prescription program on psychotropic prescribing patterns in long-term care facilities. Ann Pharmacother. 1992;26:539–46.PubMedGoogle Scholar
  4. 4.
    Cooper JR, Czechowicz DJ, Peterson RC, Molinari SP. Prescription drug diversion control and medical practice. JAMA. 1992;268:1306–10.PubMedCrossRefGoogle Scholar
  5. 5.
    Glass RM. Benzodiazepine prescription regulation: autonomy and outcome. JAMA. 1991;266:2431–3.PubMedCrossRefGoogle Scholar
  6. 6.
    Stimmel B. Pain, Analgesia and Addiction: The Pharmacologic Treatment of Pain. New York: Raven Press, 1983.Google Scholar
  7. 7.
    Khojasteh A, Evans W, Reynolds RD. Controlled-release oral morphine sulfate in the treatment of cancer pain with pharmacokinetic correlation. J Clin Oncol. 1987;5:956–61.PubMedGoogle Scholar
  8. 8.
    Jasinski DR. Assessment of the abuse potentiality of morphinelike drugs. In: Martin WR (ed). Handbook of Experimental Pharmacology. Heidelberg, Germany: Springer Verlag, 1977.Google Scholar
  9. 9.
    Roberts J. In Focus. Emerg Med News. 1992;6:3–5.Google Scholar
  10. 10.
    Crews JC, Denson DD. Recovery of morphine from a controlled-release preparation. Cancer. 1990;66:2642–4.PubMedCrossRefGoogle Scholar
  11. 11.
    National Institute on Drug Abuse. Data from the Drug Abuse Warning System, 1977. NIDA Statistical Series; 1988. U.S. Department of Health and Human Services publication ADM 88-1854.Google Scholar
  12. 12.
    National Household Survey on Drug Abuse: Population Estimates 1990. Rockville, MD: National Institute on Drug Abuse, 1991. U.S. Department of Health and Human Services publication ADM 91-1732.Google Scholar
  13. 13.
    Melzack R. The tragedy of needless pain. Sci Am. 1990;162:19–25.Google Scholar
  14. 14.
    Selbst SM, Clark M. Analgesic use in the emergency department. Ann Emerg Med. 1990;19:1010–3.PubMedCrossRefGoogle Scholar
  15. 15.
    Marks RM, Sachar EJ. Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med. 1973;78:173–81.PubMedGoogle Scholar
  16. 16.
    Agency for Health Care Policy and Research. Acute Pain Management: Operative or Medical Procedures and Trauma. U.S. Department of Health and Human Services, 1992. AHCPR 92-0032.Google Scholar
  17. 17.
    American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. Skokie, IL: American Pain Society, 1992.Google Scholar
  18. 18.
    Brookoff D, Polomano R. Treating sickle cell pain like cancer pain. Ann Intern Med. 1992;116:364–8.PubMedGoogle Scholar

Copyright information

© Hanley & Befus, inc. 1993

Authors and Affiliations

  • Daniel Brookoff
    • 1
  1. 1.Department of Medical EducationMethodist Hospitals of MemphisMemphis

Personalised recommendations